Similarly, Wang et al. [39] reported that FcRL3 expression is particularly elevated in patients with newly diagnosed, active RA, and that receptor expression levels on B cells correlate positively with DAS28 disease activity scores—evidence of its direct involvement in the initiation and persistence of inflammation and autoimmunity in RA [9,21]. This evidence concerns the gene FCRL3 and rheumatoid arthritis.